WTA reduces reading parameters and NVA

Article

With-the-rule astigmatism (WTA) reduces reading parameters and near visual acuity (NVA) compared with against-the-rule astigmatism (ATR) and no astigmatism, according to a recent paper.

With-the-rule astigmatism (WTA) reduces reading parameters and near visual acuity (NVA) compared with against-the-rule astigmatism (ATR) and no astigmatism, according to a recent paper.

Professor Thomas Kohnen et al., Department of Ophthalmology, Johann Wolfgang Goethe-University, Germany, conducted a consecutive case series on 23 eyes of 23 participants. All subjects were fogged with 0 D, −0.75 D and −1.5 D of ATR astigmatism via lenses with spherical compensation.

Every participant was cyclopleged and distance corrected The outcome measures included reading acuity (RAc), reading speed (RS) and NVA. Data was compared using the outcomes of Wilcoxon-matched-pairs test, regression analysis and Bland–Altman analysis.

Increasing the amount of astigmatism caused a decreased NVA and RAc, whereas WTR astigmatism caused a reduced NVA, RAc and RS compared to the results of ATR astigmatism.

Outcomes revealed that that NVA was better than RAc with no astigmatism, −0.75 D WTR and −1.5 D WTR. The study group did not observe any differences between NVA and RAc for −0.75 D ATR and −1.5 D ATR.

For more information on the study please visit the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.